Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

Phase 4

Completed

• Conditions: Type I Allergy
• Interventions: Other: Skin Prick Test

• Registration Number: NCT00665483
• Lead Sponsor: Allergopharma GmbH & Co. KG

Brief Summary

Multicenter Skin Prick Test

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03
• Primary Completion: 2007-09
• Study First Submitted: 2008-04-22
• Study First Submitted QC: 2008-04-23
• Study First Posted: 2008-04-24
• Study Completion: 2010-11
• Status Verified: 2013-11
• Last Update Submitted: 2013-11-07
• Last Update Posted: 2013-11-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• anamnesis referring to suspicion of an IgE-mediated allergy
• positive Skin Prick Test in the medical history to at least one of the investigational allergens with an existing anamnesis

Exclusion Criteria

• serious chronic diseases
• Other perennial allergies

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
1	Skin Prick Test	Skin Prick Test

Primary Outcome Measures

Name	Time	Method
Optimal trade-off between sensitivity and specificity	December 2007 - December 2008

Secondary Outcome Measures

Name	Time	Method
Evaluation of the documentation of adverse events	January - December 2008

Trial Locations

Locations (1)

Klinikum Darmstadt; 🇩🇪 Darmstadt, Hessen, Germany